uniQure (QURE) Liabilities and Shareholders Equity (2015 - 2026)
uniQure (QURE) posted Liabilities and Shareholders Equity of $985.1 million for Q2 2026, up 26.51% on a QoQ basis from $778.7 million in Q1 2026, and up 68.43% year-over-year from $584.9 million in Q2 2025.
Powered by 
Analysis
uniQure (QURE) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends
uniQure has reported Liabilities and Shareholders Equity for 12 years, with the latest figure at $985.1 million in Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 68.43% year-over-year to $985.1 million in Q2 2026; TTM through Jun 2026 was $3.5 billion, a 45.33% increase from a year earlier, with the FY2025 full-year figure at $824.9 million, up 48.22% from the prior year.
- Liabilities and Shareholders Equity was $985.1 million for Q2 2026 at uniQure, up from $778.7 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $985.1 million in Q2 2026, with the low at $556.5 million in Q4 2024.
- Average Liabilities and Shareholders Equity over 5 years is $747.2 million, with a median of $744.0 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity surged 108.09% in 2022, then tumbled 33.08% in 2024.
- Over 5 years, Liabilities and Shareholders Equity stood at $705.0 million in 2022, then rose by 17.98% to $831.7 million in 2023, then sank by 33.08% to $556.5 million in 2024, then jumped by 48.22% to $824.9 million in 2025, then increased by 19.42% to $985.1 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $985.1 million (Q2 2026), $778.7 million (Q1 2026), and $824.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 27.42 Bn |
| 10 | uniQure | 2.96 Bn | 2.96 Bn | 5.49 Mn | 985.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 985.10 Mn |
| Mar 31, 2026 | 778.71 Mn |
| Dec 31, 2025 | 824.91 Mn |
| Sep 30, 2025 | 888.38 Mn |
| Jun 30, 2025 | 584.89 Mn |
| Mar 31, 2025 | 605.40 Mn |
| Dec 31, 2024 | 556.54 Mn |
| Sep 30, 2024 | 645.81 Mn |
| Jun 30, 2024 | 730.85 Mn |
| Mar 31, 2024 | 770.05 Mn |
| Dec 31, 2023 | 831.69 Mn |
| Sep 30, 2023 | 871.55 Mn |
| Jun 30, 2023 | 942.77 Mn |
| Mar 31, 2023 | 631.00 Mn |
| Dec 31, 2022 | 704.96 Mn |
| Sep 30, 2022 | 638.23 Mn |
| Jun 30, 2022 | 701.21 Mn |
| Mar 31, 2022 | 757.15 Mn |
| Dec 31, 2021 | 809.18 Mn |
| Sep 30, 2021 | 774.63 Mn |
API Access
uniQure Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=QURE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "QURE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=QURE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();